Retinitis Pigmentosa: From Genetic Insights to Innovative Therapeutic Approaches—A Literature Review
Open Access
Abstract
Retinitis pigmentosa (RP) is a heterogeneous group of inherited retinal dystrophies characterized by progressive photoreceptor degeneration and vision loss. While current management is largely supportive—relying on visual aids, orientation training, and nutritional supplementation—these interventions offer only symptomatic relief and do not halt disease progression. Advances in molecular genetics have led to the development of targeted treatments, including gene replacement therapy, RNA-based therapies, and CRISPR/Cas9 gene editing, offering promising strategies for disease modification. The approval of voretigene neparvovec for RPE65-associated RP marked a milestone in gene therapy, while ongoing trials targeting mutations in RPGR, USH2A, and CEP290 are expanding therapeutic options. Optogenetic therapy and stem cell transplantation represent additional strategies, particularly for patients with advanced disease. Challenges persist in delivery efficiency, immune responses, and treating large or dominant-negative mutations. Non-viral vectors, nanoparticle systems, and artificial intelligence-guided diagnostics are being explored to address these limitations and support personalized care. This review summarizes the current and emerging therapeutic landscape for RP, highlighting the shift toward precision medicine and the need for continued innovation to overcome genetic and phenotypic variability.Keywords
This publication has 77 references indexed in Scilit:
- Phase 1/2 AAV5-hRKp.RPGR (Botaretigene Sparoparvovec) Gene Therapy: Safety and Efficacy in RPGR-Associated X-Linked Retinitis PigmentosaAmerican Journal of Ophthalmology, 2024
- Redox Status in Retinitis Pigmentosa2023
- Reduced inspired oxygen decreases retinal superoxide radicals and promotes cone function and survival in a model of retinitis pigmentosaFree Radical Biology and Medicine, 2023
- SubILM Injection of AAV for Gene Delivery to the Retina2019
- CRISPR Ethics: Moral Considerations for Applications of a Powerful ToolJournal of Molecular Biology, 2019
- Human Germline Genome EditingThe American Journal of Human Genetics, 2017
- Microglial phagocytosis and activation underlying photoreceptor degeneration is regulated by CX3CL1‐CX3CR1 signaling in a mouse model of retinitis pigmentosaGlia, 2016
- Effective delivery of large genes to the retina by dual AAV vectorsEMBO Molecular Medicine, 2013
- Perspective on Genes and Mutations Causing Retinitis PigmentosaArchives of Ophthalmology (1950), 2007
- A Randomized Trial of Vitamin A and Vitamin E Supplementation for Retinitis PigmentosaArchives of Ophthalmology (1950), 1993